Decibel Therapeutics Competitors and Similar CompaniesClear all
Decibel Therapeutics's competitors and similar companies include ElectroCore, FIRE1, HDL Therapeutics and ReShape Lifesciences.
 Decibel Therapeutics Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance. |  ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders. |  HDL Therapeutics HDL Therapeutics is a company that develops medical devices for the treatment of coronary atherosclerosis. |  ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. | ||
Founding Date | Founding Date 2015 | Founding Date 2005 | Founding Date N/A | Founding Date 2009 | Founding Date 2002 |
Type | Type Subsidiary | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US | Locations Dublin, IE HQ Dublin, IE | Locations Vero Beach, US HQ | Locations San Clemente, US HQ San Clemente, US |
Employees | Employees 6810% increase | Employees 5144% decrease | Employees 838% increase | Employees 7 | Employees 4348% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 71.2 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $32m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $11.3m (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods $4.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $5m (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit $27.8m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $6.3m (FY, 2020) |
Net income | Net income ($63m) (FY, 2022) | Net income ($14m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($21.6m) (FY, 2020) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 7.5m (about 10 years ago) | Latest funding round $ 3m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 189m | Total funding raised $ 127m | Total funding raised $ 7.5m | Total funding raised $ 7.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ElectroCore
HQ
Rockaway, US
Employees
51↓ 44% decrease
ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
View company
FIRE1
HQ
Dublin, IE
Employees
83↑ 8% increase
FIRE1 focuses on developing novel remote monitoring devices.
View companyHDL Therapeutics
HQ
Vero Beach, US
Employees
7
HDL Therapeutics is a company that develops medical devices for the treatment of coronary atherosclerosis.
View companyReShape Lifesciences
HQ
San Clemente, US
Employees
43↓ 48% decrease
ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
View company